Covetrus, Inc.
CVETNASDAQHealthcare
$20.99
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$21.2
52W Low$13.39
Covetrus, Inc. (CVET) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CVET · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.58B | $4.34B | $3.98B | $3.78B | $3.58B |
| Cost of Revenue | $3.72B | $3.54B | $3.23B | $3.09B | $2.93B |
| Gross Profit | $0.86B | $0.80B | $0.75B | $0.68B | $0.65B |
| Gross Margin %(computed) | 18.75% | 18.39% | 18.84% | 18.11% | 18.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.87B | $0.81B | $0.54B | $0.52B |
| Total Operating Expenses | $0.88B | $0.87B | $0.81B | $0.54B | $0.52B |
| Operating Income | ($0.02B) | ($0.07B) | ($1.00B) | $0.14B | $0.14B |
| Operating Margin %(computed) | -0.48% | -1.59% | -25.08% | 3.63% | 3.78% |
| Interest Income | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.05B | $0.06B | $0.00B | $0.00B |
| Income Before Tax | ($0.05B) | ($0.03B) | ($1.03B) | $0.14B | $0.14B |
| Income Tax Expense | $0.03B | ($0.01B) | ($0.01B) | $0.04B | $0.05B |
| Net Income | ($0.09B) | ($0.02B) | ($1.02B) | $0.10B | $0.06B |
| Net Margin %(computed) | -1.88% | -0.44% | -25.63% | 2.67% | 1.80% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.63 | $-0.16 | $-9.52 | $0.91 | $0.58 |
| Wtd Avg Shares | 0.14B | 0.12B | 0.11B | 0.11B | 0.11B |
| EBITDA | $0.18B | $0.21B | ($0.79B) | $0.20B | $0.17B |
| EBITDA Margin %(computed) | 3.91% | 4.91% | -19.97% | 5.35% | 4.79% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Covetrus, Inc. data
About Covetrus, Inc. (CVET) Income Statement
Covetrus, Inc. (CVET) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, CVET reported revenue of $4.58B, gross profit of $0.86B (gross margin 18.75%), and net income of ($0.09B) — a net profit margin of -1.88%.
Frequently asked questions
CVET · 4 questionsCovetrus, Inc. (CVET) reported revenue of $4.58B for 2021, up 5.4% year-over-year.
CVET revenueCVET salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08